Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Nicotine Dependence and Acute Depression

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age at least 18 at the beginning of the study~* Smoking at least 10 cigarettes a day (1/2 pack)~* Meets DSM-IV criteria for major depressive episode~Exclusion Criteria:~* Currently pregnant~* Currently breastfeeding~* Currently diagnosed with a seizure disorder, liver disease, kidney disease, congestive heart failure or diabetes mellitis~* History of a seizure, seizure disorder, significant head trauma or central nervous system tumor~* Family history of seizures~* Currently using intravenous drugs~* Currently using any drugs (marijuana, alcohol, cocaine, opiates, stimulants, etc.) on a daily basis~* Currently using any over-the-counter stimulants and anorectics (diet pills)~* Currently on fluoxetine (Prozac), bupropion (Wellbutrin, Wellbutrin SR, Wellbutrin XL) or any other antidepressants, monoamine oxidase inhibitors, antipsychotics, benzodiazepines, theophylline, systemic steroids or levodopa~* Currently on NRT or bupropion (Zyban)~* Current or past diagnosis of anorexia nervosa~* Previous allergic response to fluoxetine, bupropion, or NRT~* Previous failed quit attempt using NRT and bupropion in combination~* Current suicidal ideation~* Current or past psychosis, mania/hypomania, or any other Axis I or Axis II psychiatric diagnosis other than major depression and nicotine dependence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Bupropion (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).